Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systematic Analysis and Biomarker Study for Alzheimer's Disease.

Xinzhong Li1, Haiyan Wang2, Jintao Long3

  • 1Plymouth University Faculty of Medicine and Dentistry, Drake Circus, Plymouth, PL4 8AA, UK. xinzhong.li@plymouth.ac.uk.

Scientific Reports
|November 28, 2018
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Electrochemical Detection of Aβ42 and Aβ40 at Attomolar Scale via Optimised Antibody Loading on Pyr-NHS-Functionalised 3D Graphene Foam Electrodes.

Biosensors·2025
Same author

Early detection of Alzheimer's disease: From multiplex assays and imaging to point of care devices and AI-based functional monitoring.

Journal of Alzheimer's disease : JAD·2025
Same author

Electrochemical Immunosensor Using COOH-Functionalized 3D Graphene Electrodes for Sensitive Detection of Tau-441 Protein.

Biosensors·2025
Same author

A gut-brain axis on-a-chip platform for drug testing challenged with donepezil.

Lab on a chip·2025
Same author

Human gut epithelium features recapitulated in MINERVA 2.0 millifluidic organ-on-a-chip device.

APL bioengineering·2023

This study analyzed gene expression in Alzheimer's Disease (AD) blood and brain tissues, identifying shared dysfunctional genes and pathways. Novel risk genes and a machine learning model for AD detection were discovered.

Area of Science:

  • Genomics
  • Neuroscience
  • Biomarkers

Background:

  • Alzheimer's Disease (AD) pathology is complex, involving genetic and molecular dysfunctions.
  • Understanding shared molecular changes in blood and brain is crucial for AD diagnosis and treatment.

Purpose of the Study:

  • To identify differentially expressed genes (DEGs) common to blood and brain in Alzheimer's Disease (AD) and mild cognitive impairment (MCI) patients.
  • To discover novel AD risk genes and develop a predictive classification model.

Main Methods:

  • Systematic analysis of DEGs in blood (245 AD, 143 MCI, 182 controls) and comparison with brain tissue data.
  • Evaluation using independent AD blood datasets and gene-based genome-wide association study.
  • Development of a machine learning classification model using identified DEGs.

Related Experiment Videos

Main Results:

  • Identified 789 (AD) and 998 (MCI) common DEGs in blood and brain, with over 77% showing consistent regulation.
  • Validated known gene ABCA7 and identified novel risk genes TYK2 and TCIRG1.
  • Developed a machine learning model (NDUFA1, MRPL51, RPL36AL) distinguishing AD patients with 78.1% accuracy.

Conclusions:

  • Mitochondrial dysfunction, NF-κB, and iNOS signaling pathways are significantly dysregulated in AD pathogenesis.
  • Shared blood-brain gene expression patterns offer potential biomarkers for AD.
  • Novel genes and a predictive model advance understanding and detection of Alzheimer's Disease.